Sign in to fuzzto save your conversations, follow your research and come back anytime.
Mankind Pharma
SectorHealthcare
| Metric (₹ crore) | Q4 FY22 | Q1 FY23 | Q2 FY23 | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,725.76 | 2,180 | 2,425.84 | 2,090.93 | 2,052.67 | 2,578.62 | 2,708.1 | 2,606.95 | 2,422.24 | 2,867.85 | 3,061.43 | 3,198.79 | 3,079.37 | 3,570.35 | 3,697.16 | 3,567.2 | 3,442.93 | 4,030.59 |
| Expenses | 1,440.93 | 1,723.79 | 1,835.13 | 1,653.89 | 1,635.99 | 1,923.81 | 2,025.45 | 2,000.45 | 1,835.94 | 2,196.29 | 2,214.24 | 2,382.8 | 2,396.18 | 2,723.58 | 2,775.83 | 2,647.77 | 2,513.05 | 2,974.4 |
| EBITDA | 284.83 | 456.21 | 590.71 | 437.04 | 416.68 | 654.81 | 682.65 | 606.5 | 586.3 | 671.56 | 847.19 | 815.99 | 683.19 | 846.77 | 921.33 | 919.43 | 929.88 | 1,056.19 |
| Depreciation | 47.36 | 78.02 | 78.59 | 84.79 | 84.52 | 87.35 | 96.49 | 109.72 | 99.78 | 102.69 | 100.49 | 187.17 | 230.87 | 218.68 | 221.82 | 222.6 | 223.08 | 225.7 |
| EBIT | 237.47 | 378.19 | 512.12 | 352.25 | 332.16 | 567.46 | 586.16 | 496.78 | 486.52 | 568.87 | 746.7 | 628.82 | 452.32 | 628.09 | 699.51 | 696.83 | 706.8 | 830.49 |
| Interest | 13.03 | 16.24 | 10.31 | 12.76 | 5.16 | 6.34 | 8.62 | 9.19 | 9.17 | 10.84 | 7.1 | 220.93 | 190.54 | 170.65 | 169.68 | 157.2 | 141.75 | 109.98 |
| Profit Before Tax | 224.44 | 361.95 | 501.81 | 339.49 | 327 | 561.12 | 577.54 | 487.59 | 477.35 | 558.03 | 739.6 | 407.89 | 261.78 | 457.44 | 529.83 | 539.63 | 565.05 | 720.51 |
| Net Profit | 192.71 | 297.64 | 422.62 | 295.72 | 293.7 | 494.19 | 511.18 | 459.81 | 476.59 | 543.07 | 658.88 | 384.52 | 424.65 | 444.62 | 520.18 | 413.88 | 559.42 | 574.09 |
| EPS | 4.74 | 7.3 | 10.48 | 7.09 | 7.13 | 12.15 | 12.51 | 11.33 | 11.76 | 13.39 | 16.31 | 9.46 | 10.19 | 10.62 | 12.39 | 9.9 | 13.44 | 13.76 |
| Metric (₹ crore) | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 1,069.71 | 1,137.24 | 919.78 | 1,813.3 | 2,152.44 | 2,413.38 | 3,121.29 |
| Investing Cash Flow | -435.55 | -1,221.84 | -1,368.67 | -1,051.81 | -2,080.52 | -12,624.1 | -180.79 |
| Financing Cash Flow | -530.74 | -7.81 | 604.62 | -739.73 | 5.27 | 10,232.6 | -2,952.69 |
| Net Cash Flow | 103.42 | -92.41 | 155.73 | 21.76 | 77.19 | 21.88 | -12.19 |
| Metric (₹ crore) | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 4,862.89 | 6,316.31 | 7,623.29 | 9,575.79 | 14,568.19 | 16,561.01 |
| Total Liabilities | 1,509.75 | 2,831.42 | 2,092.16 | 2,387.46 | 13,191.35 | 11,518.48 |
| Total Assets | 6,372.63 | 9,147.74 | 9,715.45 | 11,963.2 | 27,759.5 | 28,079.5 |